ArticleScientific reports2026
An exploratory analysis of the effects of human FYN and its Drosophila ortholog in Drosophila tissues.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Many cancers are initiated by the activation of oncogenes, which cause cancer phenotypes through a variety of disruptive mechanisms. FYN is a human proto-oncogene implicated in many cancers, especially those of the central nervous system and ovary. FYN encodes a non-receptor tyrosine kinase from the Src tyrosine kinase family, and has been shown to promote proliferation and metastasis. Our previous publication demonstrated that introduction of human FYN in the Drosophila eye resulted in a deleterious effect on eye structure, suggesting potential conserved functions across species. This study utilized the Gal4-UAS system to express a wildtype version of human FYN and a constitutively active form of its Drosophila ortholog, Src64B, in the eye and ovary of Drosophila melanogaster, to further explore their conserved functions. Our findings suggested that overexpression of FYN and Src64B in Drosophila eye tissue exhibited conserved developmental defects and a rough eye phenotype. FYN overexpression in the Drosophila ovary demonstrated accumulation of anterior egg chamber squamous cells without associated proliferative activity. These accumulated squamous cells exhibited altered expressions of apical, basolateral, and Par-complex polarity factors. Constitutive expression of Src64B showed similar phenotypes. These results indicate that the conserved oncogenic potential of FYN may be linked to changes in cell polarity signaling, which is considered a hallmark of cancer.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.